A startup recently located in the BioLabs-LA at the Lundquist, an Institute for Biomedical Innovation at Harbor-UCLA Medical Center., SNJ Pharma Inc. was established explcitly to develop the portfolios of the Korean based firm JINIS Inc. for access to the global market. JINIS Inc. was originally founded in Korea by by Dr. Hyeon Jin Kim - now also President of SNJ Pharma here in the US. After 20 years of rigorous R/D at JINIS, SNJ Pharma is now the means by which to develop the portfolios of JINIS that are at various preclinical and clinical stages. An approriate BSIR endeavor???